114 related articles for article (PubMed ID: 7862701)
1. Primate performance decrements following acute soman exposure: failure of chemical countermeasures.
Blick DW; Murphy MR; Brown GC; Hartgraves SL
Pharmacol Biochem Behav; 1994 Nov; 49(3):503-10. PubMed ID: 7862701
[TBL] [Abstract][Full Text] [Related]
2. Behavioral toxicity of anticholinesterases in primates: effects of daily repeated soman exposure.
Blick DW; Weathersby FR; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1994 Jul; 48(3):643-9. PubMed ID: 7938117
[TBL] [Abstract][Full Text] [Related]
3. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
4. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions.
Blick DW; Kerenyi SZ; Miller S; Murphy MR; Brown GC; Hartgraves SL
Pharmacol Biochem Behav; 1991 Mar; 38(3):527-32. PubMed ID: 2068189
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning.
Shih T; Whalley CE; Valdes JJ
Toxicol Lett; 1991 Feb; 55(2):131-47. PubMed ID: 1998202
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
Koplovitz I; Gresham VC; Dochterman LW; Kaminskis A; Stewart JR
Arch Toxicol; 1992; 66(9):622-8. PubMed ID: 1482284
[TBL] [Abstract][Full Text] [Related]
7. Protection and induced reactivation of cholinesterase by HS-6 in rabbits exposed to soman.
Harris LW; Stitcher DL; Heyl WC
Life Sci; 1981 Oct; 29(17):1747-53. PubMed ID: 7300570
[No Abstract] [Full Text] [Related]
8. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
von Bredow JD; Adams NL; Groff WA; Vick JA
Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
10. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
Blick DW; Miller SA; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
[TBL] [Abstract][Full Text] [Related]
11. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity.
Wolfe AD; Blick DW; Murphy MR; Miller SA; Gentry MK; Hartgraves SL; Doctor BP
Toxicol Appl Pharmacol; 1992 Dec; 117(2):189-93. PubMed ID: 1471150
[TBL] [Abstract][Full Text] [Related]
12. The protection of primates against soman poisoning by pretreatment with pyridostigmine.
Dirnhuber P; French MC; Green DM; Leadbeater L; Stratton JA
J Pharm Pharmacol; 1979 May; 31(5):295-9. PubMed ID: 37298
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
[TBL] [Abstract][Full Text] [Related]
14. Effects of soman and its antidotes on tracheal mucociliary transport of ferrets.
Marin MG; Zwierzynski D; McBride RK; Culp DJ
J Appl Physiol (1985); 1989 Mar; 66(3):1390-6. PubMed ID: 2496095
[TBL] [Abstract][Full Text] [Related]
15. Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman.
Heyl WC; Harris LW; Stitcher DL
Drug Chem Toxicol; 1980; 3(3):319-32. PubMed ID: 7449657
[TBL] [Abstract][Full Text] [Related]
16. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion.
Sánchez-Fortún S; Barahona V
Environ Toxicol Chem; 2001 Sep; 20(9):2008-13. PubMed ID: 11521828
[TBL] [Abstract][Full Text] [Related]
17. Assessing pyridostigmine efficacy by response surface modeling.
Jones DE; Carter WH; Carchman RA
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S242-51. PubMed ID: 4092892
[TBL] [Abstract][Full Text] [Related]
18. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman.
Dirnhuber P; Green DM
J Pharm Pharmacol; 1978 Jul; 30(7):419-25. PubMed ID: 27607
[TBL] [Abstract][Full Text] [Related]
20. Protection from lethality and behavioral incapacitation resulting from intoxication by soman (pinacolyl methylphosphonofluoridate) and treatment with atropine sulfate and 2-PAM chloride in the guinea pig, cavia porcellus.
Romano JA; Terry MR; Murrow ML; Mays MZ
Drug Chem Toxicol; 1991; 14(1-2):21-44. PubMed ID: 1889376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
